胶原酶I GIBCO 17100017 英文名称: 胶原酶I GIBCO17100017 | |||||
型号:null 产品货号: 17100017 | |||||
价格:请致电:010-57128832,18610462672 | |||||
品牌: 美国 | |||||
产品简介胶原酶I 美国GIBCO (价格优惠)Prepared from Clostridium histolyticum for dissociation of tissues.Suggested for epithelial, lung, fat, and adrenal tissue cell preparations. 产品详细信息
Collagenase Cat. No.: 17100 Type I 17101 Type II 17102 Type III 17103 Hepatocyte Qualified 17104 Type IV Sizes: See catalog. Custom pack sizes available upon request. Storage: 2 to 8°C (-5 to -20°C after reconstitution) Avoid moisture and exposure to light. Avoid inhalation and skin contact. This product is intended for cell or tissue disaggregation only. Background Collagenase (from clostridium histolyticum) is a protease with a specificity for the bond between a neutral amino acid (x) and glycine in the sequence Pro-X-Glyc-Pro. This sequence is found in high frequency in collagen and is unique among proteases in its ability to degrade the triplehelical native collagen fibrils commonly found in connective tissue. The collagenase most commonly used for tissue dissociation is a crude preparation containing clostripiopeptidase A and a number of other proteases, polysaccharidases and lipases. This crude enzyme is ideally suited for tissue dissociation since it contains the enzyme required to attack native collagen and reticular fibers, in addition to the enzymes which hydrolyze the other proteins, polysaccharides and lipids in the extracellular matrix of connective and epithelial tissues. Crude collagenase does exhibit lot-to-lot variability and may produce occasional toxicity. Invitrogen attempted to minimize these difficulties by tissue-typing their crude collagenase lots based upon a correlation between various enzyme levels in each preparation and effectiveness in dissociating certain tissues. Specifications Potency: One unit liberates 1 μM of L-leucine equivalents from collagen in 5 hours at +37°C, pH 7.5. Types: Particular enzymatic activities of crude collagenases have correlated with the tissues from which the cells were obtained (or with the uses to which the cells are put), and as a result of the correlation’s, several formal types have been established. Type III Selected because of low proteolytic activity. (casein as substrate) Type IV Selected because of low tryptic activity. (BAEE as substrate) These selected types have been found to give better performance in preparation of cells from the various tissues as tabulated below. It should be noted, however, that while the results have been greatly improved following this classification, there is still some lot-to-lot variation, and efforts continue in attempting to gain even better control over crude collagenase. TYPE TISSUES OR CELLS I Fat cells, Adrenal, Liver II Heart, Bone, Thyroid, Cartilage, Liver III Mammary IV Islet (insulin receptor sites) Inhibitors: Metal chelating agents such as cysteine, EDTA or o-phenanthroline but not DFP. It is also inhibited by a2-macroglobulin, a large plasma glycoprotein. Instructions for use A. Preparing stock and working solution Dissolve the non-sterile, lyophilized enzyme in HBSS (Cat. No. 14025). Filter sterilize the solution with a cell culture approved filtration unit. Crude collagenase is most often used in concentrations from 0.1 to 0.5% (W/V) or 50 to 100 U/mL. Once reconstituted use immediately or store frozen. Thaw in refrigerator immediately prior to use. B. Dissociation of tissue • Tissue is minced with a sterile scalpel or scissors. • Wash the tissue several times in HBSS. • The tissue fragments are soaked at +37°C. Increased efficiency is obtained using a rocker platform and supplementing the digest with 3 mM CaCl2. C. Organ perfusion • Digest is prewarmed to +37°C and perfused at a rate preoptimized for the particular organ. Addition of 3 mM CaCl2 increases the efficiency of dissociation. • Dispersed cells and tissue fragments are separated from larger pieces by passing the mixture through a sterile stainless steel or nylon mesh. Fresh collagenase solution can be added to the fragments if further disaggregation is required. • Wash several times to eliminate debris and enzyme solution. A density separation step (Nycodenz) will give a cleaner suspension. • Resuspend the pellet in the culture medium and incubate under predetermined conditions. For further information on this or other GIBCOTM products, contact Technical Services at the following: United States TECH-LINE SM : 1 800 955 6288 Canada TECH-LINE: 1 800 757 8257 Outside the U.S. and Canada, refer to the GIBCO products catalogue for the TECH-LINE in your region. You may also contact your Invitrogen Sales Representative or our World Wide Web site at www.invitrogen.com. For research use only. CAUTION: Not intended for human or animal diagnostic or therapeutic uses. |